Expression analysis of MDR1, BCRP and MRP3 transporter proteins in different in vitro and ex vivo cornea models for drug absorption studies.
暂无分享,去创建一个
[1] Stephan Reichl,et al. In vitro cell culture models to study the corneal drug absorption , 2011, Expert opinion on drug metabolism & toxicology.
[2] E. Y. Zhang,et al. Characterization of Human Corneal Epithelial Cell Model As a Surrogate for Corneal Permeability Assessment: Metabolism and Transport , 2009, Drug Metabolism and Disposition.
[3] A. Mitra,et al. Modulation of P-glycoprotein-mediated efflux by prodrug derivatization: an approach involving peptide transporter-mediated influx across rabbit cornea. , 2006, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[4] A. Mitra,et al. Molecular Expression and Functional Evidence of a Drug Efflux Pump (BCRP) in Human Corneal Epithelial Cells , 2009, Current eye research.
[5] A. Urtti,et al. Culture model of human corneal epithelium for prediction of ocular drug absorption. , 2001, Investigative ophthalmology & visual science.
[6] A. Urtti,et al. Ocular Pharmacokinetic Modeling Using Corneal Absorption and Desorption Rates from in Vitro Permeation Experiments with Cultured Corneal Epithelial Cells , 2003, Pharmaceutical Research.
[7] Tao Zhang,et al. Drug Transporter and Cytochrome P450 mRNA Expression in Human Ocular Barriers: Implications for Ocular Drug Disposition , 2008, Drug Metabolism and Disposition.
[8] C. Xia,et al. EXPRESSION, LOCALIZATION, AND FUNCTIONAL CHARACTERISTICS OF BREAST CANCER RESISTANCE PROTEIN IN CACO-2 CELLS , 2005, Drug Metabolism and Disposition.
[9] A. I. Schneider,et al. The use of an in vitro cornea for predicting ocular toxicity , 1997 .
[10] K. Hayashi,et al. An SV 40-Immortalized Human Corneal Epithelial Cell Line and Its Characterization , 2005 .
[11] Olivier Fardel,et al. Analysis of drug transporter expression in human intestinal Caco‐2 cells by real‐time PCR , 2007, Fundamental & clinical pharmacology.
[12] H. Sasaki,et al. Delivery of drugs to the eye by topical application , 1996, Progress in Retinal and Eye Research.
[13] H. Sugihara,et al. Reconstruction of cornea in three-dimensional collagen gel matrix culture. , 1993, Investigative ophthalmology & visual science.
[14] Shufeng Zhou,et al. Multidrug resistance associated proteins as determining factors of pharmacokinetics and pharmacodynamics of drugs. , 2007, Current drug metabolism.
[15] A Rzhetsky,et al. The human ATP-binding cassette (ABC) transporter superfamily. , 2001, Journal of lipid research.
[16] D. Monti,et al. Development of cultured rabbit corneal epithelium for drug permeation studies: a comparison with excised rabbit cornea. , 2004, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[17] C. Müller-Goymann,et al. [Development of an organotypic corneal construction as an in vitro model for permeability studies]. , 2001, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.
[18] M. Häkli,et al. Effluxing ABC transporters in human corneal epithelium. , 2010, Journal of pharmaceutical sciences.
[19] M. Prausnitz,et al. Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. , 1998, Journal of pharmaceutical sciences.
[20] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[21] I. Papantoniou,et al. Reconstruction of an in vitro cornea and its use for drug permeation studies from different formulations containing pilocarpine hydrochloride. , 2001, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[22] J. Forrester,et al. The suprabasal layer of corneal epithelial cells represents the major barrier site to the passive movement of small molecules and trafficking leukocytes , 2006, British Journal of Ophthalmology.
[23] Sujit K. Basu,et al. Air-Interface Condition Promotes the Formation of Tight Corneal Epithelial Cell Layers for Drug Transport Studies , 2000, Pharmaceutical Research.
[24] A. Murakami,et al. Expression and Distribution of Junctional Adhesion Molecule-1 in the Human Cornea , 2007, Japanese Journal of Ophthalmology.
[25] T. Murakami,et al. Intestinal efflux transporters and drug absorption. , 2008, Expert opinion on drug metabolism & toxicology.
[26] Stephan Reichl,et al. Development of a serum-free human cornea construct for in vitro drug absorption studies: the influence of varying cultivation parameters on barrier characteristics. , 2010, International journal of pharmaceutics.
[27] M. Engelke,et al. A Human Corneal Equivalent Constructed from SV40-immortalised Corneal Cell Lines , 2005, Alternatives to laboratory animals : ATLA.
[28] H. Handa,et al. An SV40-immortalized human corneal epithelial cell line and its characterization. , 1995, Investigative ophthalmology & visual science.
[29] V. Ganapathy,et al. Molecular evidence and functional expression of P-glycoprotein (MDR1) in human and rabbit cornea and corneal epithelial cell lines. , 2003, Investigative ophthalmology & visual science.
[30] D. Greco,et al. Gene expression analysis in SV-40 immortalized human corneal epithelial cells cultured with an air-liquid interface , 2010, Molecular vision.
[31] J. Fogh,et al. New Human Tumor Cell Lines , 1975 .
[32] S Reichl,et al. Human corneal equivalent as cell culture model for in vitro drug permeation studies , 2004, British Journal of Ophthalmology.
[33] Kazuhito Yamada,et al. Characterization of cyclosporin A transport in cultured rabbit corneal epithelial cells: P-glycoprotein transport activity and binding to cyclophilin. , 1999, Investigative ophthalmology & visual science.
[34] Kati-Sisko Vellonen,et al. Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. , 2006, Advanced drug delivery reviews.
[35] H. Sasaki,et al. Transport of acebutolol through rabbit corneal epithelium. , 2006, Biological & pharmaceutical bulletin.
[36] M. Khan,et al. Permeability of Chemical Delivery Systems Across Rabbit Corneal (SIRC) Cell Line and Isolated Corneas: A Comparative Study , 2000, Pharmaceutical development and technology.
[37] Tomi Järvinen,et al. Ocular absorption following topical delivery , 1995 .
[38] S Reichl,et al. Cultivation and characterization of a bovine in vitro model of the cornea. , 2004, Die Pharmazie.
[39] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[40] M. Braun,et al. Establishing and functional testing of a canine corneal construct. , 2008, Veterinary ophthalmology.
[41] Stephan Reichl,et al. Prevalidation of a human cornea construct as an alternative to animal corneas for in vitro drug absorption studies. , 2012, Journal of pharmaceutical sciences.
[42] Y. Kawashima,et al. Beta adrenergic antagonist permeation across cultured rabbit corneal epithelial cells grown on permeable supports. , 1998, Current eye research.
[43] C. Ehrhardt,et al. A Comparative Evaluation of Corneal Epithelial Cell Cultures for Assessing Ocular Permeability , 2008, Alternatives to laboratory animals : ATLA.
[44] M. Niemi,et al. Membrane transporters in drug development , 2010, Nature Reviews Drug Discovery.
[45] Stephan Reichl,et al. Cell culture models of the human cornea — a comparative evaluation of their usefulness to determine ocular drug absorption in‐vitro , 2008, The Journal of pharmacy and pharmacology.
[46] Ulf Norinder,et al. Identification of Novel Specific and General Inhibitors of the Three Major Human ATP-Binding Cassette Transporters P-gp, BCRP and MRP2 Among Registered Drugs , 2009, Pharmaceutical Research.
[47] G. Szakács,et al. Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. , 2006, Physiological reviews.
[48] C. Müller-Goymann,et al. [Esterase activity of human organotypic cornea construct (HCC) as in vitro model for permeation studies]. , 2005, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.
[49] Y. Omidi,et al. Ocular novel drug delivery: impacts of membranes and barriers. , 2008, Expert opinion on drug delivery.
[50] K. Ruprecht,et al. Expression of ABC-transporters in human corneal tissue and the transformed cell line, HCE-T. , 2007, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[51] S. Reich,et al. Entwicklung eines organotypischen Korneakonstruktes als ein In-vitro-Modell für Permeationsstudien , 2001, Der Ophthalmologe.
[52] E. Toropainen,et al. Paracellular and passive transcellular permeability in immortalized human corneal epithelial cell culture model. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[53] L. Meyer,et al. Esteraseaktivität eines organotypischen humanen Kornea-Konstrukts (HCC) als In-vitro-Modell für Permeationsuntersuchungen , 2005, Der Ophthalmologe.
[54] W. Duan,et al. Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development. , 2008, Current medicinal chemistry.
[55] M. Griffith,et al. Functional human corneal equivalents constructed from cell lines. , 1999, Science.
[56] Y. Omidi,et al. Ocular novel drug delivery: impacts of membranes and barriers , 2008, Expert opinion on drug delivery.